INVESTOR RELATIONS OVERVIEW STOCK INFORMATION ANALYST INFORMATION PRESS RELEASES CALENDAR PRESENTATIONS FINANCIAL REPORTS SEC FILINGS CORPORATE GOVERNANCE INVESTOR FAQS EMAIL ALERTS CONTACT

Corporate Profile Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification and targeting of disease at the molecular level to improve patient healthcare by addressing significant unmet needs. The company is focused on discovering, developing and commercializing innovative and targeted radiotherapeutics and molecular imaging pharmaceuticals with initial applications in the areas of oncology and cardiology. Molecular Insight’s lead radiotherapeutic product candidates, Azedra and Onalta, are under development for the treatment of cancer. The company’s lead molecular imaging pharmaceutical product candidate, Zemiva, is under development for the diagnosis of cardiac ischemia, or insufficient blood flow to the heart. In addition, the company has a growing pipeline of product candidates resulting from application of its proprietary platform technologies to new and existing compounds. Stock Quote MIPI (Common Stock) Exchange NASDAQ (US Dollar) Price $5.62 Change (%)   0.03 (0.53%) Volume 86,913 Data as of 07/03/08 1:00 p.m. ET Minimum 20 minute delay Refresh quote Recent News More >> Date Title   06/19/08 Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference 06/18/08 Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex(TM) Program for Prostate Cancer Diagnosis and Staging 06/18/08 Molecular Insight Pharmaceuticals, Inc. Reports Onalta(TM) Tissue Distribution Data Support Clinical Development Program 06/16/08 Molecular Insight Pharmaceuticals, Inc. Reports Preclinical Data on Solazed(TM) for Treatment of Metastatic Melanoma at Society of Nuclear Medicine (SNM) Meeting Upcoming Events More >> There are currently no events scheduled. Featured Report   2007 Annual Review Receive E-mail Alerts Sign up to receive e-mail alerts whenever Molecular Insight Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.